Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00194740 · ClinicalTrials.gov registry record · Phase 2
Taxotere Plus Weekly Navelbine and G-CSF: A Study in Stage IV Breast Cancer
A Phase 2 study, sponsored by University of Washington.
- Completed
- Registry status
- Phase 2
- Development phase
- 48
- Enrollment target
NCT00194740 is a Phase 2 study that has completed, run by University of Washington. The registered enrollment target is 48 participants.
The verdict
NCT00194740, a Phase 2 study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 48 participants
- Enrollment target
Study Summary
The two drugs used to treat metastatic breast cancer in this study may perform better when used together than when used separately. The use of another drug that prevents the most common side effect of the two-drug combination permits the delivery of both agents at closer to the "full" dose for either when used alone. We hypothesize that the two-drug combination used with G-CSF support will be more effective and less toxic than other standard regimens for the treatment of metastatic breast cancer.
Interventions
- DRUG Docetaxel
- DRUG Filgrastim
- DRUG Vinorelbine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 1997-11 |
| Est. Completion | 2007-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00194740
The ClinicalTrials.gov registry entry for NCT00194740 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Docetaxel is the first listed.
NCT00194740 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00194740 about?
NCT00194740 is a clinical study titled "Taxotere Plus Weekly Navelbine and G-CSF: A Study in Stage IV Breast Cancer". The two drugs used to treat metastatic breast cancer in this study may perform better when used together than when used separately. The use of another drug that prevents the most common side effect of the two-drug combination permits the delivery of both agents at closer to the "full" dose for eithe...
What is the current status of trial NCT00194740?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 48 participants. The study started on 1997-11. Estimated completion is 2007-06.
What interventions are being tested in trial NCT00194740?
The interventions under investigation include: Docetaxel (DRUG), Filgrastim (DRUG), Vinorelbine (DRUG).
Who is sponsoring clinical trial NCT00194740?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.